The drug, Diclegis, failed to meet minimum effectiveness goals in the clinical trial relied upon by the U.S. Food and Drug Administration for its approval in 2013, Canadian researchers reported.



from WebMD Health http://ift.tt/2FMaGwn

Related Posts:

0 comments:

Post a Comment

Popular Posts